Picodya is a startup company developing a revolutionary immunoassay diagnostics platform, capable of running a panel of tests for multiple patients in parallel in a fully automated manner, thus reducing dramatically cost, labor and wait times.This high-throughput low-cost platform is suitable for mass deployment anywhere from hospital departments, to outpatient clinics and home care uses. Picodyas B-Matrix system brings rapid IV diagnostics to any location, bypassing the need for central labs, specialist personnel, complex logistics, and long wait times. Thanks to sophisticated AI analysis, doctors can receive reliable, actionable results within just 15 minutes saving time and saving lives.
Startup Profile Funding Rounds
AI Technology Stack
On top of its diagnostics platform, Picodya is building a multi-layered AI solution that will translate the tests results into a sophisticated decision support tool providing clinicians with reliable, actionable insights.